Source: BioPortfolio

Genera Biosystems: Genera Biosystems Ltd GBI Financial and Strategic SWOT Analysis Review Report Updated 07082017 Prices from USD $300

SummaryGenera Biosystems Ltd GBL is a medical equipment company which develops and commercializes multiplexed molecular diagnostic testing products. It offers products such as RTIplex and PapType. GBL's RTIplex is a multiplexed and automated PCR based test...

Read full article »
Est. Annual Revenue
<$1M
Agree?
Est. Employees
<10
Agree?
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100